Expert: the availability of medicines in Europe could soon be significantly impacted by supply chain dependency on Asia on March 29, 2023 Speaking during the opening ceremony of Olainfarm’s conference “Health. Security. Pharmacy”, European Commission Executive Vice-President and Trade Commissioner Valdis Dombrovskis… Expert: the availability of medicines in Europe could soon be significantly impacted by supply chain dependency on Asia03.29.2023
Olainfarm: People are the key to success on March 22, 2023 This year, the biggest pharmaceutical company in the Baltic States and the industry leader in Latvia AS Olainfarm turns 50. The… Olainfarm: People are the key to success03.22.2023
Olainfarm will invest EUR 100 million in developing its product portfolio and modernising production for the introduction of new products on March 20, 2023 Advancing the company’s development and continuing its reorientation to western markets, with a planned investment of EUR 100 million over… Olainfarm will invest EUR 100 million in developing its product portfolio and modernising production for the introduction of new products03.20.2023
Decision-makers and experts at a conference agree that investments in healthcare and pharmacy are a prerequisite for a healthy society and economic growth on March 10, 2023 “Health. Security. Pharmacy”, the first major conference in Latvia devoted to the importance of healthcare and the pharmaceutical industry to… Decision-makers and experts at a conference agree that investments in healthcare and pharmacy are a prerequisite for a healthy society and economic growth03.10.2023
Valdis Dombrovskis: the Pharmaceutical Sector is Vital to Economic Growth on March 9, 2023 Today, 9 March, “Health. Security. Pharmacy”, the first major conference devoted to the importance of healthcare and the pharmaceutical industry… Valdis Dombrovskis: the Pharmaceutical Sector is Vital to Economic Growth03.09.2023
In response to the growing number of diabetes patients, Latvijas Aptieka will provide free insulin needles on March 7, 2023 The number of sugar diabetes patients in Latvia is growing and is approaching the 100,000 boundary. In order to encourage… In response to the growing number of diabetes patients, Latvijas Aptieka will provide free insulin needles03.07.2023
Olainfarm invests over EUR 100,000 in developing an educational platform for doctors and pharmacists on March 2, 2023 In order to facilitate the further education and certification of Latvian healthcare specialists, since 2020 AS Olainfarm has been developing… Olainfarm invests over EUR 100,000 in developing an educational platform for doctors and pharmacists03.02.2023
The importance of the pharmaceutical industry to national health and security will be highlighted at a conference dedicated to Olainfarm’s 50th anniversary on February 28, 2023 Pharmacy proved itself to be a fundamental industry during Covid-19, when one virus was able to paralyse the whole world,… The importance of the pharmaceutical industry to national health and security will be highlighted at a conference dedicated to Olainfarm’s 50th anniversary02.28.2023
Olainfarm has undergone its biggest ever training with the emergency services on February 16, 2023 Today, AS Olainfarm’s territory played host to major full-scale training, in order to test an emergency situation management system designed… Olainfarm has undergone its biggest ever training with the emergency services02.16.2023
During this inflationary period, Olainfarm has paid out EUR 80,000 a month to support its employees on February 2, 2023 To reduce the inflation-driven burden of the cost of living, which in December 2022 according to Central Statistical Bureau data… During this inflationary period, Olainfarm has paid out EUR 80,000 a month to support its employees02.02.2023
For the first time in the company’s history OlainMed’s turnover tops EUR 1 million on January 24, 2023 Last year, the annual turnover of AS Olainfarm Group subsidiary – the outpatient medical service provider SIA OlainMed increased by 15%,… For the first time in the company’s history OlainMed’s turnover tops EUR 1 million01.24.2023
Juris Bundulis: The Key to the Availability of Medicines – Local Manufacturers on January 16, 2023 It is no secret that for several months now in Latvia medicines have been in acutely short supply both on… Juris Bundulis: The Key to the Availability of Medicines – Local Manufacturers01.16.2023
Компанії групи Olainfarm активно долучилися до допомоги українцям on January 8, 2023 Olainfarm є однією з найбільших фармацевтичних компаній в Латвії та інших країнах Балтії. Продукція компанії поставляється в більше ніж 60… Компанії групи Olainfarm активно долучилися до допомоги українцям01.08.2023
The companies of the Olainfarm group are actively involved in helping Ukrainians on January 8, 2023 Olainfarm is one of the largest pharmaceutical companies in Latvia and other Baltic countries. The company’s products are delivered to… The companies of the Olainfarm group are actively involved in helping Ukrainians01.08.2023
Olainfarm Consolidates Management to Boost Transition to Western Markets on September 22, 2022 Today, 22 September, the shareholders meeting of AS Olainfarm, the largest pharmaceutical company in the Baltics, endorsed the implementation of… Olainfarm Consolidates Management to Boost Transition to Western Markets09.22.2022
“Clinic DiaMed” invests 1.5 million euros in extending the Magnetic resonance imaging services on May 31, 2022 “Clinic DiaMed” plans to invest 1.5 million euros in extending the magnetic resonance imaging (MRI) service by the end of… “Clinic DiaMed” invests 1.5 million euros in extending the Magnetic resonance imaging services05.31.2022